AVBP
Price
$25.22
Change
+$0.33 (+1.33%)
Updated
Jun 20 closing price
Capitalization
862.84M
52 days until earnings call
IPSC
Price
$0.58
Change
-$0.01 (-1.69%)
Updated
Jun 20 closing price
Capitalization
49.93M
46 days until earnings call
Interact to see
Advertisement

AVBP vs IPSC

Header iconAVBP vs IPSC Comparison
Open Charts AVBP vs IPSCBanner chart's image
ArriVent BioPharma
Price$25.22
Change+$0.33 (+1.33%)
Volume$441.5K
Capitalization862.84M
Century Therapeutics
Price$0.58
Change-$0.01 (-1.69%)
Volume$949.46K
Capitalization49.93M
AVBP vs IPSC Comparison Chart in %
Loading...
AVBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVBP vs. IPSC commentary
Jun 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVBP is a Hold and IPSC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 22, 2025
Stock price -- (AVBP: $25.22 vs. IPSC: $0.58)
Brand notoriety: AVBP and IPSC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVBP: 169% vs. IPSC: 114%
Market capitalization -- AVBP: $862.84M vs. IPSC: $49.93M
AVBP [@Biotechnology] is valued at $862.84M. IPSC’s [@Biotechnology] market capitalization is $49.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $333.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVBP’s FA Score shows that 0 FA rating(s) are green whileIPSC’s FA Score has 0 green FA rating(s).

  • AVBP’s FA Score: 0 green, 5 red.
  • IPSC’s FA Score: 0 green, 5 red.
According to our system of comparison, AVBP is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVBP’s TA Score shows that 5 TA indicator(s) are bullish while IPSC’s TA Score has 5 bullish TA indicator(s).

  • AVBP’s TA Score: 5 bullish, 4 bearish.
  • IPSC’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AVBP is a better buy in the short-term than IPSC.

Price Growth

AVBP (@Biotechnology) experienced а +8.38% price change this week, while IPSC (@Biotechnology) price change was +1.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.57%. For the same industry, the average monthly price growth was +27.78%, and the average quarterly price growth was +14.34%.

Reported Earning Dates

AVBP is expected to report earnings on Aug 13, 2025.

IPSC is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+9.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVBP($863M) has a higher market cap than IPSC($49.9M). AVBP YTD gains are higher at: -5.330 vs. IPSC (-42.386). IPSC has higher annual earnings (EBITDA): -5.99M vs. AVBP (-140.41M). AVBP has more cash in the bank: 176M vs. IPSC (165M). AVBP has less debt than IPSC: AVBP (138K) vs IPSC (52.7M). IPSC has higher revenues than AVBP: IPSC (115M) vs AVBP (0).
AVBPIPSCAVBP / IPSC
Capitalization863M49.9M1,729%
EBITDA-140.41M-5.99M2,343%
Gain YTD-5.330-42.38613%
P/E RatioN/AN/A-
Revenue0115M-
Total Cash176M165M107%
Total Debt138K52.7M0%
TECHNICAL ANALYSIS
Technical Analysis
AVBPIPSC
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
AVBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SLVIX36.75-0.04
-0.11%
Columbia Select Large Cap Value Inst2
MMMMX39.32-0.09
-0.23%
Victory Integrity Discovery Member
MOINX22.59-0.07
-0.31%
NYLI WMC Small Companies Investor Class
PAIGX20.98-0.07
-0.33%
T. Rowe Price International Value Eq Adv
PORTX58.21-0.28
-0.48%
Trillium ESG Global Equity Investor

AVBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVBP has been loosely correlated with COGT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AVBP jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVBP
1D Price
Change %
AVBP100%
+1.33%
COGT - AVBP
44%
Loosely correlated
-0.14%
ETNB - AVBP
43%
Loosely correlated
N/A
IPSC - AVBP
43%
Loosely correlated
-0.77%
IDYA - AVBP
42%
Loosely correlated
-0.87%
LGND - AVBP
42%
Loosely correlated
-0.50%
More

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
-0.77%
CRSP - IPSC
57%
Loosely correlated
-0.41%
NTLA - IPSC
51%
Loosely correlated
-4.17%
CRBU - IPSC
51%
Loosely correlated
+4.69%
RXRX - IPSC
50%
Loosely correlated
-1.57%
OCGN - IPSC
50%
Loosely correlated
-2.75%
More